4D Molecular Therapeutics Inc (FDMT)

SBC to Revenue

155.62%

Quarterly · Period ending:

FDMT logo

FDMT SBC to Revenue

Latest reported155.62%
FDMT Quarterly SBC/Revenue (7.95% → 155.62%)
High-resolution chart · PNG

FDMT sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
155.6202%
146.1437%
6.526%
5,021.1111%
33,053.3333%
49,900%
757,800%
216,333.3333%
121,460%
21,335.7143%
-31,121.0526%
22.5797%
2,079.0795%
1,416.443%
348.5164%
904%
2,667.9012%
322.6415%
4,055.4348%
287.1889%
26.1728%
116.45%
-175.7421%
15.4561%
28.5439%
30.6365%
50%
195.1852%
33.3333%
33.3333%
10.7494%
10.7494%
7.9503%
7.9503%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.